Venture Kick
Venture Kick is a private philanthropic initiative based in Zurich, Switzerland, founded in 2007 to support Swiss startups at the pre-seed stage. It provides up to 150,000 Swiss francs in funding and offers structured entrepreneurial training aimed at developing sustainable businesses. Entrepreneurs participate in a competitive process, pitching their ideas up to three times for increasing funding amounts, while receiving valuable feedback from expert juries. To date, Venture Kick has supported 600 startup projects with a total of 24.9 million francs, leading to the incorporation of 454 active companies that have created over 6,000 jobs and attracted approximately 2.49 billion francs in subsequent investments. Companies founded by Venture Kick alumni have notably achieved significant recognition, with 55 percent of the TOP 100 Swiss Startup Award in 2018 represented by these ventures. In 2019, the initiative aimed to allocate 4.35 million francs to support idea-stage projects, facilitating the transition of Swiss scientific innovations to global markets.
Top Stages
Past deals in Chemical
CellX Biosolutions
Pre Seed Round in 2025
CellX Biosolutions specializes in sustainable chemical waste management. It offers services such as custom bacterial community biodiscovery and optimization, biodegradability studies, and deployment using microfluidic devices. The company helps industries treat pollutants like PFAS, pharmaceuticals, and microplastics, and enables chemical and pharmaceutical producers to manage their waste cost-effectively and sustainably.
CellX Biosolutions
Grant in 2024
CellX Biosolutions specializes in sustainable chemical waste management. It offers services such as custom bacterial community biodiscovery and optimization, biodegradability studies, and deployment using microfluidic devices. The company helps industries treat pollutants like PFAS, pharmaceuticals, and microplastics, and enables chemical and pharmaceutical producers to manage their waste cost-effectively and sustainably.
Biosimo Chemicals
Pre Seed Round in 2022
Biosimo Chemicals is a chemical engineering start-up focused on the development and operation of processes to produce bio-based platform chemicals. The company aims to create sustainable chemical solutions through innovative catalytic reactions and purification processes. Its flagship technology offers a novel method for producing acetic acid, replacing traditional methods that rely on coal and gas with a process that utilizes ethanol derived from biomass and waste. This advancement provides the chemical, pharmaceutical, and materials industries with a direct alternative to fossil-based resources, aligning with global sustainability goals.
Biosimo Chemicals
Grant in 2022
Biosimo Chemicals is a chemical engineering start-up focused on the development and operation of processes to produce bio-based platform chemicals. The company aims to create sustainable chemical solutions through innovative catalytic reactions and purification processes. Its flagship technology offers a novel method for producing acetic acid, replacing traditional methods that rely on coal and gas with a process that utilizes ethanol derived from biomass and waste. This advancement provides the chemical, pharmaceutical, and materials industries with a direct alternative to fossil-based resources, aligning with global sustainability goals.
Bloom Biorenewables
Grant in 2020
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.
Bloom Biorenewables
Convertible Note in 2019
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.
Synple Chem
Grant in 2016
Synple Chem AG, based in Zurich, Switzerland, specializes in the development of automated reagent cartridge-based synthesizers designed to enhance the efficiency of chemical synthesis in laboratories, particularly in drug discovery. Founded in 2016, the company offers products such as Synple 1 and Synple 2, which utilize revolutionary reagent capsules to enable faster and more efficient synthesis of organic compounds. This innovative technology allows researchers, even those with limited chemistry expertise, to conduct complex reactions in a fully automated manner, simplifying the process by minimizing the need for precise measurements and reducing reagent waste. By streamlining the synthesis process, Synple Chem aims to significantly accelerate drug discovery cycles, helping researchers advance their projects more quickly than traditional methods permit.
CyanoGuard
Grant in 2016
CyanoGuard AG is a Swiss chemical technology company founded in 2016, specializing in innovative solutions for the monitoring and detection of cyanide across various sectors, including mining, food safety, wastewater, and healthcare. The company offers a range of products, including the CyanoKit, a semi-quantitative cyanide test, the CyanoGuard mobile quantitative monitoring test, and the Cyano.iO online monitoring and optimization solution. CyanoGuard's technology enables rapid and accurate cyanide detection without the need for specialized training or equipment, making it suitable for use in remote locations. The company's methods are designed to selectively detect cyanide in liquid samples while resisting interference from common substances, thereby providing clients with efficient tools for tracking and managing cyanide levels in diverse applications.
CyanoGuard
Grant in 2015
CyanoGuard AG is a Swiss chemical technology company founded in 2016, specializing in innovative solutions for the monitoring and detection of cyanide across various sectors, including mining, food safety, wastewater, and healthcare. The company offers a range of products, including the CyanoKit, a semi-quantitative cyanide test, the CyanoGuard mobile quantitative monitoring test, and the Cyano.iO online monitoring and optimization solution. CyanoGuard's technology enables rapid and accurate cyanide detection without the need for specialized training or equipment, making it suitable for use in remote locations. The company's methods are designed to selectively detect cyanide in liquid samples while resisting interference from common substances, thereby providing clients with efficient tools for tracking and managing cyanide levels in diverse applications.
SwissBlot
Grant in 2014
SwissBlot develops a method to extract chemicals from plants efficiently and provides a cost-competitive solution to substitute crude oil in products such as adhesives and coating.
DynaDes
Grant in 2012
At DynaDes, they design pre-clinical drugs using innovative and proven, proprietary computational methods that account for protein dynamics and solvation effects. Combined with their in-house designed compound libraries and synthesis resources, their unique approach is remarkably efficient in generating novel, highly selective and potent drug candidates. From the target definition up to clinical stage entry, DynaDes focuses on a streamlined approach to provide patented compounds addressing unmet medical needs. Their current pipeline of products target the ATP-binding and allosteric sites of protein kinases, epigenetic targets and protein-protein interaction sites of proteins implicated in cancer. The particular selectivity of their compounds, coupled with their potency, solubility and toxicity profiles, renders them attractive for further development by their partner companies.
DynaDes
Grant in 2012
At DynaDes, they design pre-clinical drugs using innovative and proven, proprietary computational methods that account for protein dynamics and solvation effects. Combined with their in-house designed compound libraries and synthesis resources, their unique approach is remarkably efficient in generating novel, highly selective and potent drug candidates. From the target definition up to clinical stage entry, DynaDes focuses on a streamlined approach to provide patented compounds addressing unmet medical needs. Their current pipeline of products target the ATP-binding and allosteric sites of protein kinases, epigenetic targets and protein-protein interaction sites of proteins implicated in cancer. The particular selectivity of their compounds, coupled with their potency, solubility and toxicity profiles, renders them attractive for further development by their partner companies.
SpiroChem
Grant in 2011
SpiroChem AG is a Swiss fine chemicals company based in Basel, specializing in the design, synthesis, production, and commercialization of novel building blocks for drug discovery. Founded in 2011, SpiroChem provides a diverse range of chemical entities, including bicyclo[1.1.1]pentanes, cubanes, oxetanes, spirocycles, and various other molecular fragments, tailored to support pharmaceutical, agrochemical, and life science sectors. The company leverages advanced drug design expertise and proprietary process chemistry technologies to enhance the capabilities of its clients in accelerating drug discovery and optimizing lead compounds. SpiroChem's extensive portfolio and associated services enable medicinal chemists to improve the absorption, distribution, metabolism, and excretion (ADME) properties of compounds, thereby facilitating the development of more effective drugs. Its global client base includes many leading pharmaceutical companies, reflecting SpiroChem's reputation as a preferred partner in the industry.
ACL Instruments
Grant in 2008
ACL Instruments AG is a Swiss company specializing in the development and commercialization of innovative solutions for assessing and predicting oxidative stability in organic compounds and various product formulations. Founded in 2008 as a spin-off from the Bern University of Applied Sciences, the company offers precision instruments and software designed for chemiluminescence-based analysis of oxidative reactions. ACL Instruments provides a range of services, including experimental characterization, kinetic analysis, and predictive modeling of oxidative decay, catering to diverse industries such as polymers, coatings, adhesives, fuels, pharmaceuticals, and food products. The company's focus on creating tailored solutions allows clients to enhance stability prediction, quality assurance, and safety in their products. ACL Instruments AG is headquartered in Kerzers, Switzerland, and operates as a subsidiary of ReseaChem GmbH.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.